When you choose to receive NEXIUM®, AstraZeneca Canada will provide financial savings towards the cost of your prescription
FR
InnoviCares is a program operated by STI Technologies Limited, a completely independent Canadian company that offers free financial assistance for many brand-name medications and healthcare products, including NEXIUM®.
Our main goal: to help you afford to start — or stay — on the medication and therapies prescribed by your healthcare team.
InnoviCares works in conjunction with your private or public health plans and is accepted at 98% of Canadian pharmacies.
AstraZeneca Canada, the manufacturer of NEXIUM®, has committed to fund this patient benefit through a partnership with innoviCares.
Why? Because we believe that cost shouldn’t be a barrier between you and the medications your healthcare team has prescribed for you.
In fact, AstraZeneca Canada is one of many Canadian pharmaceutical companies that have committed to fund similar programs through innoviCares. That means over 100 brand-name medications and products are now available at an equal or similar price to generic alternative(s), all with just one card.†
Your innoviCares card will cover a portion of the cost of a prescription for brand-name NEXIUM® so that you can access NEXIUM®at a similar price to the generic espramazole. The card will cover customary mark up and dispensing fees to a maximum amount based on a provincial estimate.
Present your innoviCares card to your pharmacist when you fill your prescription. The benefits associated with your product will be automatically applied. Don’t forget to ask for brand-name NEXIUM®.
